234 related articles for article (PubMed ID: 22071028)
1. Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.
Narongroeknawin P; Patkar NM; Shakoory B; Jain A; Curtis JR; Delzell E; Lander PH; Lopez-Ben RR; Pitt MJ; Safford MM; Volgas DA; Saag KG
J Clin Densitom; 2012; 15(1):92-102. PubMed ID: 22071028
[TBL] [Abstract][Full Text] [Related]
2. Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis.
Beaudouin-Bazire C; Dalmas N; Bourgeois J; Babinet A; Anract P; Chantelot C; Farizon F; Chopin F; Briot K; Roux C; Cortet B; Thomas T
Joint Bone Spine; 2013 Mar; 80(2):201-5. PubMed ID: 22999902
[TBL] [Abstract][Full Text] [Related]
3. Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures.
Spangler L; Ott SM; Scholes D
Osteoporos Int; 2011 Sep; 22(9):2523-7. PubMed ID: 21153405
[TBL] [Abstract][Full Text] [Related]
4. Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.
Napoli N; Jin J; Peters K; Wustrack R; Burch S; Chau A; Cauley J; Ensrud K; Kelly M; Black DM
J Clin Endocrinol Metab; 2012 Jul; 97(7):2414-22. PubMed ID: 22547423
[TBL] [Abstract][Full Text] [Related]
5. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
[TBL] [Abstract][Full Text] [Related]
6. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
7. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.
Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS
Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835
[TBL] [Abstract][Full Text] [Related]
8. Atypical Fractures are Mainly Subtrochanteric in Singapore and Diaphyseal in Sweden: A Cross-Sectional Study.
Schilcher J; Howe TS; Png MA; Aspenberg P; Koh JS
J Bone Miner Res; 2015 Nov; 30(11):2127-32. PubMed ID: 25950861
[TBL] [Abstract][Full Text] [Related]
9. The impact of subtrochanteric fracture criteria on hip fracture classification.
Huang SY; Grimsrud CD; Provus J; Hararah M; Chandra M; Ettinger B; Lo JC
Osteoporos Int; 2012 Feb; 23(2):743-50. PubMed ID: 21562878
[TBL] [Abstract][Full Text] [Related]
10. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
Genest F; Seefried L
Osteoporos Int; 2018 Aug; 29(8):1815-1825. PubMed ID: 29774402
[TBL] [Abstract][Full Text] [Related]
11. Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients.
Kondo N; Fukuhara T; Watanabe Y; Miyasaka D; Yamamoto N; Sato H; Wada Y; Nakatsue T; Fujisawa J; Sakuma M; Imai N; Yoda T; Narita I; Endo N
Tohoku J Exp Med; 2017 Dec; 243(4):247-254. PubMed ID: 29212985
[TBL] [Abstract][Full Text] [Related]
12. Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.
Warren C; Gilchrist N; Coates M; Frampton C; Helmore J; McKie J; Hooper G
ANZ J Surg; 2012 Dec; 82(12):908-12. PubMed ID: 22943522
[TBL] [Abstract][Full Text] [Related]
13. Differences in subtrochanteric and diaphyseal atypical femoral fractures in a super-aging prefectural area: YamaCAFe Study.
Takakubo Y; Miyaji T; Ohta D; Ito J; Oki H; Momma R; Naganuma Y; Honma R; Akabane T; Uno T; Sasaki A; Suran Y; Dairaku K; Goto S; Goto Y; Kanauchi Y; Kobayashi S; Nakajima T; Matsuda M; Masuda K; Mura N; Takenouchi K; Tsuchida H; Onuma Y; Shibuya J; Nagase T; Yamaguchi O; Urayama Y; Furukawa T; Okuda S; Huang H; Noro A; Ogura K; Nakamura T; Sasaki K; Ishi M; Takagi M
J Bone Miner Metab; 2021 Jul; 39(4):700-711. PubMed ID: 33821304
[TBL] [Abstract][Full Text] [Related]
14. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
Puhaindran ME; Farooki A; Steensma MR; Hameed M; Healey JH; Boland PJ
J Bone Joint Surg Am; 2011 Jul; 93(13):1235-42. PubMed ID: 21776577
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
Adams AL; Xue F; Chantra JQ; Dell RM; Ott SM; Silverman S; Giaconi JC; Critchlow C
Osteoporos Int; 2017 Jan; 28(1):413-417. PubMed ID: 27766369
[TBL] [Abstract][Full Text] [Related]
16. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
[TBL] [Abstract][Full Text] [Related]
17. Audit of Atypical Femoral Fractures and a Description of Some of Their Features.
Lian K; Trollip J; Sandhu S; Moosavi M; Gill A; Kendler D; Dian L; Lentle B
Can Assoc Radiol J; 2016 Feb; 67(1):69-75. PubMed ID: 26800621
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
19. Incidence of atypical nontraumatic diaphyseal fractures of the femur.
Dell RM; Adams AL; Greene DF; Funahashi TT; Silverman SL; Eisemon EO; Zhou H; Burchette RJ; Ott SM
J Bone Miner Res; 2012 Dec; 27(12):2544-50. PubMed ID: 22836783
[TBL] [Abstract][Full Text] [Related]
20. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.
Abrahamsen B; Eiken P; Eastell R
J Clin Endocrinol Metab; 2010 Dec; 95(12):5258-65. PubMed ID: 20843943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
